Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Sunho Biologics,Inc. ( (HK:2898) ) just unveiled an announcement.
Sunho Biologics, Inc. has announced a board meeting scheduled for March 31, 2025, to review and approve the company’s annual results for the year ending December 31, 2024. This meeting is significant as it will address the company’s financial performance and other business matters, potentially impacting its market positioning and stakeholder interests.
More about Sunho Biologics,Inc.
Sunho Biologics, Inc. is a company incorporated in the Cayman Islands, operating in the biotechnology industry. It focuses on developing and providing biological products and services, with a market presence reflected in its listing on the Hong Kong Stock Exchange.
YTD Price Performance: 13.03%
Average Trading Volume: 5,215
Technical Sentiment Consensus Rating: Strong Buy
See more insights into 2898 stock on TipRanks’ Stock Analysis page.